hydroxyproline has been researched along with buserelin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, W; Gold, E; Goulding, A | 1 |
| Fisher, L; Goulding, A | 2 |
| Gold, E; Goulding, A | 2 |
| Lynch, JH; O'Brien, WM | 1 |
| Fukushima, M | 1 |
| Amama, EA; Minaguchi, H; Taga, M | 1 |
1 trial(s) available for hydroxyproline and buserelin
| Article | Year |
|---|---|
Changes in bone mineral content following hormone treatment for endometriosis.
Topics: Adult; Alkaline Phosphatase; Bone Density; Buserelin; Creatinine; Danazol; Endometriosis; Estradiol; Female; Humans; Hydroxyproline; Middle Aged; Osteocalcin; Single-Blind Method | 1995 |
7 other study(ies) available for hydroxyproline and buserelin
| Article | Year |
|---|---|
Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin.
Topics: Animals; Body Weight; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Disease Models, Animal; Drug Interactions; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Organ Size; Rats; Rats, Inbred Strains; Tamoxifen; Uterus | 1992 |
Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the rat.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Clomiphene; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hydroxyproline; Rats; Rats, Inbred Strains; Uterus | 1991 |
17 beta-estradiol protects rats from osteopenia associated with administration of the luteinising hormone releasing hormone (LHRH) agonist, buserelin.
Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Buserelin; Calcium; Calcium Radioisotopes; Estradiol; Female; Hydroxyproline; Rats | 1991 |
Buserelin-mediated osteoporosis: effects of restoring estrogen on bone resorption and whole body calcium content in the rat.
Topics: Animals; Body Weight; Bone and Bones; Bone Resorption; Buserelin; Calcium; Estradiol; Female; Femur; Hydroxyproline; Osteoporosis; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Hydroxyproline as a marker for following patients with metastatic prostate cancer.
Topics: Bone Neoplasms; Buserelin; Creatinine; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Leuprolide; Male; Prostatic Neoplasms | 1988 |
Flutamide-mediated androgen blockade evokes osteopenia in the female rat.
Topics: Androgens; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Buserelin; Female; Flutamide; Hydroxyproline; Organ Size; Rats; Rats, Wistar; Uterus | 1993 |
The effect of gonadotropin-releasing hormone agonist on type I collagen C-telopeptide and N-telopeptide: the predictive value of biochemical markers of bone turnover.
Topics: Adult; Alkaline Phosphatase; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Remodeling; Buserelin; Collagen; Collagen Type I; Endometriosis; Estradiol; Female; Goserelin; Humans; Hydroxyproline; Leiomyoma; Osteocalcin; Peptides; Retrospective Studies | 1998 |